The last month of summer saw several hires, including a lead for Worldwide Clinical Trials’ Japan operations, CEO appointments at CordenPharma and LabConnect, and Altasciences’ new CSO, who joins the company from Syneos.
Velocity Clinical Research officially launches following the acquisition of three US-based sites – with plans to expand globally and become one of the leading site groups in the world, says CEO.